These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6207385)

  • 21. Measurement of androgen receptor in cytosols from normal, benign hypertrophic and cancerous human prostates.
    Shimazaki J; Hikage T; Sato R; Kodama T; Ito H
    Endocrinol Jpn; 1981 Dec; 28(6):725-34. PubMed ID: 6179768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of 3H-methyltrienolone (3H-R1881) to androgen receptors in human gingiva.
    Vittek J; Hernandez MR; Wenk EJ; Rappaport SC; Southren AL
    J Periodontal Res; 1985 Jan; 20(1):41-6. PubMed ID: 3156234
    [No Abstract]   [Full Text] [Related]  

  • 23. Characterization and measurement of the androgen receptor in human benign prostatic hyperplasia and prostatic hyperplasia and prostatic carcinoma.
    Snochowski M; Pousette A; Ekman P; Bression D; Andersson L; Högberg B; Gustafsson JA
    J Clin Endocrinol Metab; 1977 Nov; 45(5):920-30. PubMed ID: 72758
    [No Abstract]   [Full Text] [Related]  

  • 24. Androgen receptor binding activity in human prostate cancer.
    Benson RC; Utz DC; Holicky E; Veneziale CM
    Cancer; 1985 Jan; 55(2):382-8. PubMed ID: 2578085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new procedure for the quantitation of nuclear and cytoplasmic androgen receptors.
    Traish AM; Muller RE; Wotiz HH
    J Biol Chem; 1981 Dec; 256(23):12028-33. PubMed ID: 6975277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen binding in cytosol and nucleus of cells from human benign hyperplastic prostate [proceedings].
    Sirett DA; Grant JK
    J Endocrinol; 1977 Dec; 75(3):25P. PubMed ID: 73566
    [No Abstract]   [Full Text] [Related]  

  • 27. Specific binding of [3H]-methyltrienolone to both progestin and androgen binding components in human benign prostatic hypertrophy (BPH).
    Asselin J; Mélançon R; Gourdeau Y; Labrie F; Bonne C; Raynaud JP
    J Steroid Biochem; 1979 May; 10(5):483-6. PubMed ID: 88546
    [No Abstract]   [Full Text] [Related]  

  • 28. Binding of Permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate.
    Carilla E; Briley M; Fauran F; Sultan C; Duvilliers C
    J Steroid Biochem; 1984 Jan; 20(1):521-3. PubMed ID: 6200701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of [3H] methyltrienolone (R 1881) in rat prostate and human benign prostatic hypertrophy (BPH).
    Asselin J; Labrie F; Gourdeau Y; Bonne C; Raynaud JP
    Steroids; 1976 Oct; 28(4):449-59. PubMed ID: 64005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the binding of a potent synthetic androgen, methyltrienolone, to human tissues.
    Menon M; Tananis CE; Hicks LL; Hawkins EF; McLoughlin MG; Walsh PC
    J Clin Invest; 1978 Jan; 61(1):150-62. PubMed ID: 73547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supranormal nuclear content of 5 alpha-dihydrotestosterone in benign hyperplastic prostate of humans.
    Meikle AW; Collier ES; Middleton RG; Fang SM
    J Clin Endocrinol Metab; 1980 Oct; 51(4):945-7. PubMed ID: 6158523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of androgen cytosol receptor concentrations in Sertoli cells: effect of androgens.
    Sanborn BM; Wagle JR; Steinberger A
    Endocrinology; 1984 Jun; 114(6):2388-93. PubMed ID: 6202501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of prostatic secretion protein on uptake of androgen-receptor complex in prostatic cell nuclei.
    Pousette A; Björk P; Carlström K; Forsgren B; Högberg B; Gustafsson JA
    Prostate; 1981; 2(1):23-33. PubMed ID: 6974353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear androgen receptors in prostates from diabetic rats.
    Tesone M; Oliveira-Filho RM; Valle LB; Barañao JL; Foglia VG; Charreau EH
    Horm Metab Res; 1982 May; 14(5):237-40. PubMed ID: 7047345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of natural and synthetic ligands for determining androgen receptors in prostatic tumors and prostatic nodular hyperplasia].
    Kushlinskiĭ NR; Bassalyk LS; Degtiar' VG
    Med Radiol (Mosk); 1983 Aug; 28(8):13-6. PubMed ID: 6193390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of an anti-androgen (cyproterone acetate) with the androgen receptor system and its biological action in the rat ventral prostate.
    Huang JK; Bartsch W; Voigt KD
    Acta Endocrinol (Copenh); 1985 Aug; 109(4):569-76. PubMed ID: 2930988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcellular distribution of zinc in the benign and malignant human prostate: evidence for a direct zinc androgen interaction.
    Leake A; Chrisholm GD; Busuttil A; Habib FK
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):281-8. PubMed ID: 6198862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex difference in the cytosolic and nuclear distribution of androgen receptor in mouse submandibular gland.
    Kyakumoto S; Kurokawa R; Ohara-Nemoto Y; Ota M
    J Endocrinol; 1986 Feb; 108(2):267-73. PubMed ID: 3485169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demonstration and characterization of cytosol androgen receptor in rat exorbital lacrimal gland.
    Ota M; Kyakumoto S; Nemoto T
    Biochem Int; 1985 Feb; 10(2):129-35. PubMed ID: 3873241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional variation of cytosol androgen receptors throughout the diseased human prostate gland.
    Bowman SP; Barnes DM; Blacklock NJ; Sullivan PJ
    Prostate; 1986; 8(2):167-80. PubMed ID: 2419881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.